NMU

NMU

Target · Neuropeptide

NMU Neuromedin U · Neuromedin-U precursor

NMU (neuromedin U) is a secreted neuropeptide precursor of the neuromedin family. Proteolytic processing of the NMU protein yields a biologically active peptide linked to pain, stress, inflammation and feeding regulation. Browse Assay Genie's current range of NMU research reagents below, or read on for the biology behind the target.

Secreted neuropeptideNmU family memberRaised in several cancers
174 aa
Protein length
~20 kDa
Molecular weight
4q12
Gene locus
NmU family
Protein family
Target information

What is NMU (neuromedin U)?

NMU is a secreted neuropeptide that belongs to the NmU family and to the wider neuromedin family of neuropeptides. The NMU gene encodes a precursor that is proteolytically processed to generate the mature, biologically active peptide. According to the NCBI Gene summary, this peptide plays a role in pain, stress, immune-mediated inflammatory diseases and feeding regulation, which makes it a recurring subject in neuroendocrine and metabolic research.

In the UniProt annotation, NMU indirectly induces prolactin release from lactotroph cells in the pituitary gland, probably via the hypothalamic dopaminergic system. The same entry notes that this form does not function as a ligand for either NMUR1 or NMUR2, a point worth keeping in mind when designing receptor-signalling experiments and interpreting which NMU-derived species are being studied.

The NMU gene is found on human chromosome 4q12, and orthologues are annotated in mouse and rat, both named Nmu, so rodent models can be used to study its biology. Alternative splicing produces multiple transcript variants that encode different isoforms, and some of these isoforms may undergo similar processing to give the mature peptide. This is relevant when choosing which form of the precursor or peptide to measure.

Increased expression of the NMU gene has been observed in renal, pancreatic and lung cancers, and this has drawn interest in NMU as a possible marker in tumour research. HGNC classifies the gene within the neuropeptides group under the approved name neuromedin U.

Pain and stress research

NMU-derived peptide is described as playing a role in pain and stress, making it a subject of neuropeptide signalling studies.

Feeding regulation studies

The mature peptide is linked to feeding regulation, so NMU is examined in work on appetite and energy balance.

Immune-mediated inflammation

NMU is implicated in immune-mediated inflammatory diseases, supporting its study in inflammation and immunology models.

Cancer expression profiling

Increased NMU expression has been observed in renal, pancreatic and lung cancers, prompting investigation of its role in tumours.

Background

NMU frequently asked questions

What does NMU do?

NMU is a neuropeptide precursor processed into an active peptide that plays a role in pain, stress, immune-mediated inflammatory diseases and feeding regulation. UniProt also reports that it indirectly induces prolactin release from pituitary lactotroph cells, probably via the hypothalamic dopaminergic system.

Does NMU have isoforms or alternative names?

The approved name is neuromedin U, and UniProt lists the protein as Neuromedin-U. No other aliases are recorded. Alternative splicing gives multiple transcript variants encoding different isoforms, and some of these may be processed in a similar way to produce the mature peptide.

Is NMU conserved, and is it linked to disease?

Mouse and rat both carry an orthologous gene named Nmu, so rodent models are available; check the datasheet of any product for its validated reactivity. Increased NMU expression has been observed in renal, pancreatic and lung cancers, and the peptide is linked to inflammatory disease.

Explore

Related targets

Neuromedin receptors, related neuropeptides and pituitary hormones that sit alongside NMU in neuroendocrine research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P48645; product specifications from Assay Genie datasheets.

NMU Product listing